| abstract |
The present application relates to a halofuginone derivative and a pharmaceutical composition and use thereof, the halofuginone derivative is shown in formula I, wherein m is 1 to 4, n is 1 to 10, and A is H or a detection label, such as Biotin label. The present application also relates to pharmaceutical compositions comprising halofuginone derivatives of formula I and their use in the treatment of cancer. Formula I. |